Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abacavir platelet function study in HIV-positive men
ACTRN12613000570785Phase 4Completed
- Sponsor
- Alfred Health
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by Alfred Health. Primary endpoint: Change in P-VASP assay. Started Aug 2013; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12613000570785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000570785.